XIA: China's consumption upgrade is not only expanding market volume, but also elevating industry standards. As a global ...

Three new cancer drugs could help AstraZeneca make a dent in its lofty ambition to become an $80 billion company by 2030.

A new wave of startups promise to automate everyday tasks — from app development to travel planning — better than chatbots.

AstraZeneca CEO Pascal Soriot views the company's stock price — up just 10% year-to-date — as a marker of how he is doing. He ...

Long term follow-up data from the TELLOMAK Phase 2 trial in Sézary syndrome (SS) and mycosis fungoides (MF) will be presented at the ASCO Annual Meeting 2025. Long-term follow-up data from ...

Treasury Secretary Scott Bessent warned on Sunday that tariff rates will go back to "reciprocal" levels if countries do not make trade deals with the US during the 90-day pause. “President Trump has ...

as shown in the top left chart in the figure below. Coal use outside the power and chemicals sectors peaked at the same time as cement, but has been rebounding since then and is now close to previous ...

Accra, April 4, GNA – The Minister of Lands and Natural Resources, Mr Emmanuel Armah-Kofi Buah, has inaugurated the Association of China-Ghana Mining (ACGM), to champion sustainable mining, increased ...

CEOs from large pharma companies AstraZeneca ... and China will drive up production costs of medicines, according to a February survey by the trade group the Biotechnology Innovation Organization ...

Cambridge-headquartered AstraZeneca is investing ... Development Manager, helped chart the company’s growth in Cambridge, and CEO Pascal Soriot always denied any direct involvement and Business Weekly ...

AstraZeneca's booth is seen during ... "We basically have made China a critical part of our global organization. Some companies use China simply as a distribution network, but for us, China ...